News & Events
Read about the latest developments at NorthX Biologics and find out more about relevant happenings in the industry.
Lipum and NorthX Biologics enter into new strategicmanufacturing alliance
Lipum AB (Publ), a clinical stage biopharmaceutical company specialized in discovery and development of a novel treatment for chronic inflammatory diseases today announces thatit has entered into a manufacturing alliance ...
Synerkine Pharma and NorthX Biologics sign maufacturing alliance
Leiden, The Netherlands – February 19, 2024 – Synerkine Pharma, a Dutch biopharmaceutical company creating innovative pain solutions, today announced a manufacturing alliance with NorthX Biologics AB, a leading biopharmaceutical company ...
Finding your match in the biotech world: The CDMO dating game
In the dynamic and complex world of pharmaceuticals and drug development, the quest to find the right Contract Development and Manufacturing Organization (CDMO) often feels akin to searching for a ...
NorthX Biologics AB introduces proprietary AAV plasmids, bolstering comprehensive gene therapy support
MATFORS, Sweden, Nov. 01, 2023 (GLOBE NEWSWIRE) NorthX Biologics AB, a pioneer in biopharmaceutical innovation, is excited to announce the launch of its proprietary plasmids for the efficient manufacture of ...
Navigating the production of non-GMP proteins in a GMP-driven environment
As the pharmaceutical and biotechnological industries are obliged to align their operations with Good Manufacturing Practice (GMP) guidelines, a unique set of challenges emerges for facilities tasked with producing non-GMP ...
More than a hundred advanced biologics frontrunners gathered at our first-class manufacturing site in Matfors
Event summary: The future of advanced biologics On 26-28 September NorthX successfully arranged the conference ”the future of advanced biologics” where over 100 front-runners from the life science field were ...
Check out the new conference insight on what’s cooking in the ATMP space
Current trends in ATMPs This article is written by NorthX Biologics Senior Advisor Helena Strigård och Bio-works Technologies CEO Jonathan Royce. Link to Article
NorthX Biologics AB announces inauguration of Innovation Hub at Matfors facility
Matfors, Sweden (September 28 2023) NorthX Biologics AB (“NorthX”) is proud to announce the official inauguration of its state-of-the-art Innovation Hub at the Matfors facility. This significant milestone marks a ...
NorthX Biologics welcomes Dr Janet Hoogstraate as new CEO following merger with Valneva Clinical Trials Manufacturing unit
We are announcing the appointment of a new CEO Dr. Janet Hoogstraate. Janet is a distinguished leader within the biopharmaceutical sector and this move follows the company’s strategic merger with Valneva ...